- 徐州逸仕生物技术有限公司
- 新闻中心
- 专业代理Anogen抗体|免疫分析试剂盒|人源化单克隆抗体|...
- 【豪越】吉利汽车_豪越报价_豪越图片_汽车之家
- Anogen ELISA 产品介绍 BioTNT 科研好助手 生物 ...
- ...授权代理商经销商暨OriGen BioMedical与上海华雅思创生物公司...
- 深圳市杰士特生物科技有限公司怎么样?
- cosmobio|产品目录
- 请问生意经的朋友有没有做植物提取物外贸出口的呀????求解答
- Anogen中国代理艾美捷科技——免疫用高质量抗体
- 默瑞生物成为 Biotechrabbit 授权代理商 ...
- 默瑞生物成为 Biotechrabbit 授权代理商 ...
- Description
- Additional
Description
Details
Description:Mouse monoclonal antibody to human platelet membrane glycoprotein IIb/IIIa (GP IIb/IIIa)
Purification:Protein G affinity purified
Product Type: Primary antibody
Target Protein:Human platelet membrane glycoprotein IIb/IIIa
Immunogen:Human platelet suspension
Fusion Myeloma:Sp2/0-Ag14
Specificity:The mAb reacts with human platelet.
Species Reacitvity:Human, others not tested
Host / Isotype:Mouse, IgG2b Kappa
Formulation:Lyophilized from a solution in 0.01M PBS, pH 7.2
Reconstitution:Double distilled water is recommended to adjust the final concentration to 1.00mg/mL.
Storage: Store at -20oC
Research Area:Hematology, blood coagulation
Background:
Human platelet membrane glycoprotein Glycoprotein IIb/IIIa (GP IIb/IIIa) is a dominate receptor on the platelet membrane with very high molecular weight (>200kDa). After the platelet is activated, the GP IIb/IIIa receptor complex changes conformation and binds to fibrinogen in blood circulation with high affinity. The activation of platelets is initiated locally when the endothelial layer is wounded and the platelets are exposed to the collagen underneath the endothelium. The fibrinogen aggregates with platelets when binding to the GP IIb/IIIa receptor on platelets, thus primary haemostasis (Platelet clot) is formed.
Application:
ELISA:The mAb is reactive to platelet coated ELISA plate.
Other applications have not been evaluated.
References:
If research is published using this product, please inform Anogen in order to cite the reference on this datasheet. Anogen will provide one unit of product in the same category as gratitude.
Additional
Additional Information
| Product Specificity | mAb anti-Human GP IIb/IIIa, 291 |
|---|---|
| Application | EIA |
| Size | 0.1 mg |


